House
File
2377
H-8104
Amend
the
amendment,
H-8091,
to
House
File
2377
as
follows:
1
1.
Page
1,
by
inserting
before
line
2:
2
<
___.
Page
1,
by
striking
lines
9
through
21
and
inserting:
3
<
2.
a.
The
program
shall
collect
from
pharmacies
dispensing
4
information
for
controlled
substances
identified
pursuant
to
5
section
124.554,
subsection
1,
paragraph
āgā
,
and
from
first
6
responders
as
defined
in
section
147A.1,
subsection
7,
with
7
the
exception
of
emergency
medical
care
providers
as
defined
8
in
section
147A.1,
subsection
4,
administration
information
9
for
opioid
antagonists.
The
department
of
public
health
10
shall
provide
information
for
the
administration
of
opioid
11
antagonists
to
the
board
as
prescribed
by
rule
for
emergency
12
medical
care
providers
as
defined
in
section
147A.1,
subsection
13
4.
The
board
shall
adopt
rules
requiring
the
following
14
information
to
be
provided
regarding
the
administration
of
15
opioid
antagonists:
16
(1)
Patient
identification.
17
(2)
Identification
of
the
person
administering
opioid
18
antagonists.
19
(3)
The
date
of
administration.
20
(4)
The
quantity
of
opioid
antagonists
administered.
21
b.
The
information
collected
shall
be
used
by
prescribing
22
practitioners
and
pharmacists
on
a
need-to-know
basis
for
23
purposes
of
improving
patient
health
care
by
facilitating
early
24
identification
of
patients
who
may
be
at
risk
for
addiction,
25
or
who
may
be
using,
abusing,
or
diverting
drugs
for
unlawful
26
or
otherwise
unauthorized
purposes
at
risk
to
themselves
and
27
others,
or
who
may
be
appropriately
using
controlled
substances
28
lawfully
prescribed
for
them
but
unknown
to
the
practitioner.
>>
29
2.
Page
1,
by
striking
lines
9
and
10
and
inserting:
30
<
___.
By
striking
page
4,
line
29,
through
page
5,
line
4.
>
31
3.
Page
9,
by
inserting
before
line
25:
32
<
___.
Page
15,
line
19,
by
striking
<
controlled
substances
>
33
and
inserting
<
opioids
>
34
___.
Page
15,
line
23,
by
striking
<
controlled
substances
>
35
-1-
H8091.4053
(2)
87
ss/rh
1/
2
#1.
#2.
#3.
and
inserting
<
opioids
>
1
___.
Page
15,
lines
28
and
29,
by
striking
<
controlled
2
substances
>
and
inserting
<
opioids
>>
3
4.
By
renumbering,
redesignating,
and
correcting
internal
4
references
as
necessary.
5
______________________________
LUNDGREN
of
Dubuque
-2-
H8091.4053
(2)
87
ss/rh
2/
2
#4.